Pregled bibliografske jedinice broj: 545198
Detection and management of hemolytic specimens
Detection and management of hemolytic specimens // 1st EFCC-BD conference on Preanalytical Phase: Preanalytical phase quality improvement – dream or reality
Parma, Italija, 2011. (predavanje, međunarodna recenzija, pp prezentacija, znanstveni)
CROSBI ID: 545198 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Detection and management of hemolytic specimens
Autori
Šimundić, Ana-Maria
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, pp prezentacija, znanstveni
Skup
1st EFCC-BD conference on Preanalytical Phase: Preanalytical phase quality improvement – dream or reality
Mjesto i datum
Parma, Italija, 01.04.2011. - 02.04.2011
Vrsta sudjelovanja
Predavanje
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
hemolysis; preanalytical phase; errors
Sažetak
Assay interferences have long been underestimated and unfortunately too often undetected in the daily clinical laboratory practice. The extra-analytical phase of the laboratory testing process has been recognized as the major source of laboratory errors over the past decade, whereas preanalytical errors are those most commonly occurring within the total testing process. Hemolysis is recognized as one of the most prevalent preanalytical errors and surely the most prevalent interference in clinical laboratory testing. Visual detection of hemolysis is arbitrary and therefore mostly unreliable since it may over- and underestimate the actual prevalence of hemolyzed serum specimens. Elevated concentrations of bilirubin may further impair the ability to detect hemolysis by visual inspection and therefore lead to serious underestimation of hemolysis in neonatal samples where elevated bilirubin concentration is commonplace. The recent advances in laboratory technology have lead to an increasing trend in the automation of various preanalytical processes into large preanalytical modules. Such modules as well as novel automated laboratory analyzers offer the automated detection of serum indices. This is advantageous due to the increased reproducibility and the improvement in detection of mildly hemolyzed specimens. These platforms commonly use the semiquantitative spectrophotometric measurement and grade interfering substances into several categories. However, various analytical platforms may have different decision thresholds for various serum indices. Moreover, different systems might be different in their assay parameters and the degree of the interference of the specific interfering substance. Hemolysis is still one of the biggest challenges to the laboratory specialists. In case of hemolysis, laboratory personnel should always ask for new sample(s). In case new sample(s) can not be obtained, it is the responsibility of the laboratory specialist to communicate the problem with the physician responsible for the patient and seek for the best solution to the best of the patient care.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Projekti:
134-1340227-0200 - Upala i udio farmakogenetike u razvoju i ishodu akutnih i kroničnih bolesti (Šimundić, Ana-Maria, MZOS ) ( CroRIS)
Ustanove:
KBC "Sestre Milosrdnice"
Profili:
Ana-Maria Šimundić
(autor)